Shandong Longli Biological Technology Co., Ltd. is under investigation by the China Securities Regulatory Commission for alleged violations of securities laws. The company's stock has been suspended from listing and entered a delisting period starting June 1, 2020. Investors are advised to exercise caution due to ongoing risks associated with the investigation.
Summary generated by AI · Always verify with source document
Due to the company's information disclosure suspected of violating securities laws, it is currently under investigation by the China Securities Regulatory Commission (CSRC). The company's stock has been decided to be delisted by the Shenzhen Stock Exchange, entering a delisting adjustment period on June 1, 2020, after which the stock will be delisted after 30 trading days. Investors are advised to invest cautiously and pay attention to risks.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.